Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.9 CHF | -0.46% | +3.32% | +2.83% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | Reliance Insider Sold Shares Worth $1,449,067, According to a Recent SEC Filing | MT |
Sales 2024 * | 222M 244M | Sales 2025 * | 243M 267M | Capitalization | 304M 335M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 28 30.8 | EV / Sales 2024 * | 1.28 x |
Net cash position 2024 * | 19.67M 21.64M | Net cash position 2025 * | 28.1M 30.92M | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
11.6
x | P/E ratio 2025 * |
11.4
x | Employees | 616 |
Yield 2024 * |
3.2% | Yield 2025 * |
3.34% | Free-Float | 48.24% |
1 day | -0.46% | ||
1 week | +3.32% | ||
Current month | +3.32% | ||
1 month | +0.93% | ||
3 months | +2.83% | ||
6 months | +11.79% | ||
Current year | +2.83% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 10.9 | -0.46% | 17 504 |
24-05-07 | 10.95 | 0.00% | 16,099 |
24-05-06 | 10.95 | +2.82% | 17,901 |
24-05-03 | 10.65 | -0.93% | 10,608 |
24-05-02 | 10.75 | +1.90% | 45,641 |
Delayed Quote Swiss Exchange, May 08, 2024 at 11:31 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.83% | 337M | |
+3.06% | 43.86B | |
+164.78% | 5.25B | |
+3.02% | 3.07B | |
-0.19% | 2.95B | |
+95.40% | 1.2B | |
-30.48% | 1.15B | |
+68.23% | 1.09B | |
-7.66% | 1.02B | |
-14.47% | 937M |
- Stock Market
- Equities
- RSGN Stock